July 30 -- WEDNESDAY, July 29 (HealthDay News) -- Malaria parasites in western Cambodia have become resistant to artemisinin-based drugs, a development that could put millions of lives at risk, ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according ...

Clinical Trial in Africa Finds Single-Dose Malaria Treatment Combining Four Existing Drugs as Effective as More Onerous Multi-Day, Multi-Dose Regimen Research advance from Gabon presented at the ...

The malaria parasite Plasmodium falciparum is becoming increasingly resistant to the artemisinin-based combination therapies (ACTs) currently in use. Researchers at the Bernhard Nocht Institute for ...

A tumultuous, roaring river flows by a bank full of stones, some of which are arranged in a precariously balanced and gravity-defying sculpture. A tiny disturbance in the overall equilibrium can send ...

Artemisinin, a sesquiterpene lactone derived from Artemisia annua, has long been recognised for its antimalarial properties and is now under increasing scrutiny for its potential anticancer effects.

Every year, malaria kills more than 600,000 people worldwide. Most of them are children under 5 in sub-Saharan Africa. But the disease isn’t confined to poor, rural areas – it’s a global threat that ...

The path to a malaria-free world demands renewed global and domestic commitment. The strengthening of health systems to ...

Explore the challenges and progress of the Asia-Pacific region in achieving malaria elimination by 2030 amidst funding issues and treatment resistance.